KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Long-Term Investments (2018 - 2026)

Takeda Pharmaceutical has reported Long-Term Investments over the past 9 years, most recently at $56.1 million for Q1 2026.

  • For Q1 2026, Long-Term Investments fell 20.78% year-over-year to $56.1 million; the TTM value through Mar 2026 reached $56.1 million, down 20.78%, while the annual FY2026 figure was $58.4 million, 17.6% down from the prior year.
  • Long-Term Investments was $56.1 million for Q1 2026 at Takeda Pharmaceutical, down from $70.8 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $2.3 billion in Q1 2024 and bottomed at $56.1 million in Q1 2026.
  • The 5-year median for Long-Term Investments is $831.0 million (2022), against an average of $1.1 billion.
  • Year-over-year, Long-Term Investments surged 154.42% in 2023 and then crashed 96.92% in 2025.
  • Over 5 years, Long-Term Investments stood at $831.0 million in 2022, then surged by 154.42% to $2.1 billion in 2023, then rose by 8.75% to $2.3 billion in 2024, then crashed by 96.92% to $70.8 million in 2025, then fell by 20.78% to $56.1 million in 2026.
  • The last three reported values for Long-Term Investments were $56.1 million (Q1 2026), $70.8 million (Q1 2025), and $2.3 billion (Q1 2024) per Business Quant data.